A MULTICENTER, RANDOMIZED, CONTROLLED TRIAL TO EVALUATE THE EFFECT OF PROPHYLACTIC OCTREOTIDE ON ERCP-INDUCED PANCREATITIS

被引：0
|
作者：
STAS, KJF [1 ]
LAMBERTS, SWJ [1 ]
机构：
[1] UNIV HOSP GASTHUISBERG,DEPT INTERNAL MED,B-3000 LOUVAIN,BELGIUM
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 1993年 / 88卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1461 / 1462
页数：2
相关论文
共 50 条
  • [41] Mild ERCP-induced and non-ERCP-related acute pancreatitis: two distinct clinical entities
    Abid, G
    Siriwardana, HP
    Ahmed, T
    El-Dhuwaib, Y
    Ahmed, F
    Holt, A
    Ammori, BJ
    BRITISH JOURNAL OF SURGERY, 2004, 91 : 100 - 100
  • [42] Octreotide at High Dose in the Treatment of Acute Pancreatitis: A Prospective Randomized Controlled Trial
    Wang, Rui
    Yang, Fan
    Wu, Hao
    Wang, Yu-Fang
    Hu, Bing
    Zhang, Ming-Guang
    Tang, Chengwei
    GASTROENTEROLOGY, 2012, 142 (05) : S62 - S62
  • [43] A randomized controlled multicentric trial on the role of octreotide in human acute pancreatitis.
    Uhl, W
    Malfertheiner, P
    Adler, G
    Bruch, HP
    Lankisch, PG
    Lorenz, D
    Gaus, W
    Beger, HG
    Buchler, MW
    GASTROENTEROLOGY, 1997, 112 (04) : A488 - A488
  • [44] 24-hour prophylaxis with octreotide in high-risk patients for post-ERCP pancreatitis: Results of a multicenter, randomized trial.
    Testoni, PA
    Bagnolo, F
    Andriulli, A
    Bernasconi, G
    Crotta, S
    Lella, F
    Lomazzi, A
    Minoli, GG
    Natale, C
    Prada, A
    Toti, GL
    Zambelli, A
    GASTROINTESTINAL ENDOSCOPY, 2001, 53 (05) : AB97 - AB97
  • [45] ERCP-induced pancreatitis in primary sclerosing cholangitis: Risk factors and proposed scoring system for guiding prophylactic pancreatic stent therapy
    Gleeson, Ferga C.
    Baron, Tocild H.
    Enders, Felicity
    Gores, Gregor J.
    Gossard, Andrea A.
    Gostout, Christopher J.
    Lindor, Keith D.
    Petersen, Bret T.
    Topazian, Mark D.
    Levy, Michael J.
    GASTROINTESTINAL ENDOSCOPY, 2008, 67 (05) : AB153 - AB153
  • [46] Use of udenafil is not associated with a reduction in post-ERCP pancreatitis: results of a randomized, placebo-controlled, multicenter trial
    Oh, Hyoung-Chul
    Cheon, Young Koog
    Cho, Young Deok
    Do, Jae Hyuk
    GASTROINTESTINAL ENDOSCOPY, 2011, 74 (03) : 556 - 562
  • [47] Urinary trypsinogen activation peptides (TAP) are not increased in mild ERCP-Induced pancreatitis
    Banks, PA
    CarrLocke, DL
    Slivka, A
    VanDam, J
    Lichtenstein, DR
    Hughes, M
    PANCREAS, 1996, 12 (03) : 294 - 297
  • [48] Urinary trypsinogen-2 test strip in detecting ERCP-induced pancreatitis
    Kemppainen, E
    Hedstrom, J
    Puolakkainen, P
    Halttunen, J
    Sainio, V
    Haapiainen, R
    Stenman, UH
    ENDOSCOPY, 1997, 29 (04) : 247 - 251
  • [49] ERCP-INDUCED PANCREATITIS - DO NONIONIC CONTRAST AGENTS DECREASE PANCREATIC INJURY
    MOSLEY, RG
    REICHELDERFER, M
    LEE, FT
    FISCHER, MC
    ECKHOFF, D
    OBERLEY, T
    WEISS, J
    GASTROINTESTINAL ENDOSCOPY, 1995, 41 (04) : 426 - 426
  • [50] Chronic pancreatitis (PCS) due to ERCP-induced pancreatic duct injury.
    Lo, SK
    Koksal, R
    Lee, ER
    GASTROINTESTINAL ENDOSCOPY, 1997, 45 (04) : 550 - 550
12345